Guaifenesin Tablet, Extended Release
Product Images NDC 41415-997

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 41415-997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Publix Super Markets, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1200 mg Extended-Release Tablet Blister Pack Carton)

Principal Display Panel (1200 mg Extended-Release Tablet Blister Pack Carton)
The packaging label for Guaifenesin Extended Release Tablets, 1200 mg, branded as mucusrelief, an expectorant. The label states 12-hour maximum strength and includes 14 extended-release tablets. Distributed by Publix Super Markets, the label features the tablet's actual size and dosage instructions along with drug facts and warnings on the back panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.